These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31841873)

  • 1. Personality traits, ventricular tachyarrhythmias, and mortality in patients with an implantable cardioverter defibrillator: 6 years follow-up of the WEBCARE cohort.
    Broers ER; Habibović M; Denollet J; Widdershoven JWMG; Alings M; Theuns DAMJ; van der Voort P; Bouwels L; Herrman JP; Pedersen SS
    Gen Hosp Psychiatry; 2020; 62():56-62. PubMed ID: 31841873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-Reported Quality of Life as a Predictor of Mortality and Ventricular Tachyarrhythmia's During 7 Years' Follow-Up in Patients With an Implantable Cardioverter Defibrillator (from the MIDAS Study).
    van Veen B; Andersen CM; Johansen JB; Theuns DA; Pedersen SS
    Am J Cardiol; 2019 Feb; 123(4):605-610. PubMed ID: 30553508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of anxiety and risk associated with ventricular arrhythmia in patients with an implantable cardioverter defibrillator.
    Habibović M; Pedersen SS; Broers ER; Alings M; Theuns DAMJ; van der Voort PH; Bouwels L; Herrman JP; Denollet J
    Int J Cardiol; 2020 Jul; 310():80-85. PubMed ID: 32046911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimism as predictor of patient-reported outcomes in patients with an implantable cardioverter defibrillator (data from the WEBCARE study).
    Habibović M; Broers E; Heumen D; Widdershoven J; Pedersen SS; Denollet J
    Gen Hosp Psychiatry; 2018; 50():90-95. PubMed ID: 29127812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular tachyarrhythmias and mortality in patients with an implantable cardioverter defibrillator: impact of depression in the MIDAS cohort.
    Mastenbroek MH; Versteeg H; Jordaens L; Theuns DA; Pedersen SS
    Psychosom Med; 2014 Jan; 76(1):58-65. PubMed ID: 24336430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic importance of distressed (Type D) personality and shocks in patients with an implantable cardioverter defibrillator.
    Denollet J; Tekle FB; Pedersen SS; van der Voort PH; Alings M; van den Broek KC
    Int J Cardiol; 2013 Sep; 167(6):2705-9. PubMed ID: 22809538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depressive symptoms in patients with an implantable cardioverter defibrillator: Does treatment expectations play a role?
    Pedersen SS; Andersen CM; Denollet J; Habibovic M
    Gen Hosp Psychiatry; 2018; 51():10-14. PubMed ID: 29268165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriate Shocks and Mortality in Patients With Versus Without Diabetes With Prophylactic Implantable Cardioverter Defibrillators.
    Junttila MJ; Pelli A; Kenttä TV; Friede T; Willems R; Bergau L; Malik M; Vandenberk B; Vos MA; Schmidt G; Merkely B; Lubinski A; Svetlosak M; Braunschweig F; Harden M; Zabel M; Huikuri HV; Sticherling C;
    Diabetes Care; 2020 Jan; 43(1):196-200. PubMed ID: 31645407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type-D personality but not implantable cardioverter-defibrillator indication is associated with impaired health-related quality of life 3 months post-implantation.
    Pedersen SS; Theuns DA; Muskens-Heemskerk A; Erdman RA; Jordaens L
    Europace; 2007 Aug; 9(8):675-80. PubMed ID: 17434891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiety, depression, ventricular arrhythmias and mortality in patients with an implantable cardioverter defibrillator: 7 years' follow-up of the MIDAS cohort.
    Andersen CM; Theuns DAMJ; Johansen JB; Pedersen SS
    Gen Hosp Psychiatry; 2020; 66():154-160. PubMed ID: 32866884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving sudden cardiac death risk stratification by evaluating electrocardiographic measures of global electrical heterogeneity and clinical outcomes among patients with implantable cardioverter-defibrillators: rationale and design for a retrospective, multicenter, cohort study.
    Waks JW; Hamilton C; Das S; Ehdaie A; Minnier J; Narayan S; Niebauer M; Raitt M; Tompkins C; Varma N; Chugh S; Tereshchenko LG
    J Interv Card Electrophysiol; 2018 Jun; 52(1):77-89. PubMed ID: 29541969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pessimism and the risk for coronary heart disease among middle-aged and older Finnish men and women: a ten-year follow-up study.
    Pänkäläinen MT; Kerola TV; Hintikka JJ
    BMC Cardiovasc Disord; 2015 Oct; 15():113. PubMed ID: 26432506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pessimism and risk of death from coronary heart disease among middle-aged and older Finns: an eleven-year follow-up study.
    Pänkäläinen M; Kerola T; Kampman O; Kauppi M; Hintikka J
    BMC Public Health; 2016 Nov; 16(1):1124. PubMed ID: 27852243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the implantable cardioverter-defibrillator on rehospitalizations.
    Valenti R; Schlåpfer J; Fromer M; Fischer A; Kappenberger L
    Eur Heart J; 1996 Oct; 17(10):1565-71. PubMed ID: 8909915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Type D personality and outcomes in patients with non-ischemic heart failure.
    Bundgaard JS; Østergaard L; Gislason G; Thune JJ; Nielsen JC; Haarbo J; Videbæk L; Olesen LL; Thøgersen AM; Torp-Pedersen C; Pedersen SS; Køber L; Mogensen UM
    Qual Life Res; 2019 Nov; 28(11):2901-2908. PubMed ID: 31292822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of accelerated ventricular tachyarrhythmias on mortality in patients with implantable cardioverter-defibrillator therapy.
    Schukro C; Leitner L; Siebermair J; Pezawas T; Stix G; Kastner J; Schmidinger H
    Int J Cardiol; 2013 Sep; 167(6):3006-10. PubMed ID: 23017814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of transvenous cardioverter-defibrillator implantation on quality of life, depression and optimism in dialysis patients: report on the secondary outcome of QOL in the randomized controlled ICD2 trial.
    Timal RJ; de Gucht V; Rotmans JI; Hensen LCR; Buiten MS; de Bie MK; Putter H; Schalij MJ; Rabelink TJ; Jukema JW
    Qual Life Res; 2021 Jun; 30(6):1605-1617. PubMed ID: 33606179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiety and risk of ventricular arrhythmias or mortality in patients with an implantable cardioverter defibrillator.
    Habibović M; Pedersen SS; van den Broek KC; Theuns DA; Jordaens L; van der Voort PH; Alings M; Denollet J
    Psychosom Med; 2013 Jan; 75(1):36-41. PubMed ID: 23197843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.
    Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL
    J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.